The IPO premium has slipped to ₹48, down from ₹108 just a few days ago. While the stock is still expected to see decent listing gains, the decline in GMP signals a softening in investor sentiment ahead of the debut.
The IPO premium has slipped to ₹48, down from ₹108 just a few days ago. While the stock is still expected to see decent listing gains, the decline in GMP signals a softening in investor sentiment ahead of the debut.